The Impact of a Personalized Care Intervention on 90-day Post-Discharge Care

Sponsor
Laguna Health, Inc (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT06146582
Collaborator
Mayo Clinic (Other)
187
1
2
25.5
7.3

Study Details

Study Description

Brief Summary

The purpose of this 90 day study is to demonstrate the extent to which participants with cardiovascular conditions can improve their recovery at home through a mobile app, support and resources made available to them after hospitalization. The study will evaluate the effectiveness of personal care intervention support, including one-on-one guidance, educational information, check-ins, and Laguna's mobile app to help participants recover better after hospitalization.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Laguna Coach and App Intervention Group
N/A

Detailed Description

This study was designed to provide support to a select group of participants by supplementing the hospital-provided discharge instructions. Laguna integrated hospital provided clinical guidance and Laguna's personalized contextual care protocols, with the goal of improving health outcomes and reducing readmissions within 90 days post-discharge.

Particiants in the intervention group received support from Laguna Health via Laguna's mobile app, phone, video, text, or web chat. Laguna provided contextual support to remove recovery barriers to these intervention participants.

Study Design

Study Type:
Interventional
Actual Enrollment :
187 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants were assigned upon consent randomly to an intervention or control group. The intervention group received support from Laguna Coaches and Laguna's mobile app for 90 days, the control group did not receive any support from Laguna coaches or Laguna's app.Participants were assigned upon consent randomly to an intervention or control group. The intervention group received support from Laguna Coaches and Laguna's mobile app for 90 days, the control group did not receive any support from Laguna coaches or Laguna's app.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of a Personalized Care Intervention on 90-day Post-Discharge Care
Actual Study Start Date :
Nov 15, 2021
Actual Primary Completion Date :
Oct 5, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Arm

Group received support from Laguna Coaches

Behavioral: Laguna Coach and App Intervention Group
Behavioral, mental and contextual support was delivered through personal interactions with Laguna Coaches via mobile app, phone, video, or web chat. Care interventions were individualized to best match each participant's needs and strengths. Support will be provided to participants through interactions over approximately 90 days.

No Intervention: Control Arm

Group received no support from Laguna Coaches

Outcome Measures

Primary Outcome Measures

  1. Unplanned All Cause Readmission Rate [90 Days Post-Discharge]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admitted to the hospital with a diagnosis of a cardiovascular disorder as defined by the coded diagnoses for that admission

  • Discharged to home

  • Converse in English

  • Uses a telephone (landline or cell phone)

Exclusion Criteria:
  • Participant unable to provide informed consent

  • Participant lacks cognitive ability to participate in the study interventions as judged by the individual initiating the consenting process

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Laguna Health, Inc
  • Mayo Clinic

Investigators

  • Principal Investigator: Thomas P Olson, Ph.D., M.S., Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laguna Health, Inc
ClinicalTrials.gov Identifier:
NCT06146582
Other Study ID Numbers:
  • 21-003810
First Posted:
Nov 24, 2023
Last Update Posted:
Nov 24, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Laguna Health, Inc
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 24, 2023